Metabolome of pancreatic juice delineates distinct clinical profiles of pancreatic cancer and reveals a link between glucose metabolism and PD-1+Cells: Cancer Immunology Research

N. Cortese, G. Capretti, M. Barbagallo, A. Rigamonti, P.G. Takis, G.F. Castino, D. Vignali, G. Maggi, F. Gavazzi, C. Ridolfi, G. Nappo, G. Donisi, M. Erreni, R. Avigni, D. Rahal, P. Spaggiari, M. Roncalli, P. Cappello, F. Novelli, P. MontiA. Zerbi, P. Allavena, A. Mantovani, F. Marchesi

Research output: Contribution to journalArticlepeer-review

Abstract

Better understanding of pancreatic diseases, including pancreatic ductal adenocarcinoma (PDAC), is an urgent medical need, with little advances in preoperative differential diagnosis, preventing rational selection of therapeutic strategies. The clinical management of pancreatic cancer patients would benefit from the identification of variables distinctively associated with the multiplicity of pancreatic disorders. We investigated, by 1H nuclear magnetic resonance, the metabolomic fingerprint of pancreatic juice (the biofluid that collects pancreatic products) in 40 patients with different pancreatic diseases. Metabolic variables discriminated PDAC from other less aggressive pancreatic diseases and identified metabolic clusters of patients with distinct clinical behaviors. PDAC specimens were overtly glycolytic, with significant accumulation of lactate, which was probed as a disease-specific variable in pancreatic juice from a larger cohort of 106 patients. In human PDAC sections, high expression of the glucose transporter GLUT-1 correlated with tumor grade and a higher density of PD-1+T cells, suggesting their accumulation in glycolytic tumors. In a preclinical model, PD-1+ CD8 tumor-infiltrating lymphocytes differentially infiltrated PDAC tumors obtained from cell lines with different metabolic consumption, and tumors metabolically rewired by knocking down the phosphofructokinase (Pfkm) gene displayed a decrease in PD-1+ cell infiltration. Collectively, we introduced pancreatic juice as a valuable source of metabolic variables that could contribute to differential diagnosis. The correlation of metabolic markers with immune infiltration suggests that upfront evaluation of the metabolic profile of PDAC patients could foster the introduction of immunotherapeutic approaches for pancreatic cancer. © 2020 American Association for Cancer Research Inc.. All rights reserved.
Original languageEnglish
Pages (from-to)493-505
Number of pages13
JournalCancer Immunol. Res.
Volume8
Issue number4
DOIs
Publication statusPublished - 2020

Keywords

  • 3 hydroxybutyric acid
  • 6 phosphofructokinase
  • acetic acid
  • acetoacetic acid
  • acetone
  • alanine
  • CD8 antigen
  • citric acid
  • formic acid
  • glucose
  • glucose transporter 1
  • glutamine
  • glycine
  • isoleucine
  • lactic acid
  • leucine
  • phenylalanine
  • programmed death 1 receptor
  • succinic acid
  • tryptophan
  • tyrosine
  • valine
  • animal cell
  • animal experiment
  • animal model
  • animal tissue
  • Article
  • cancer staging
  • cancer tissue
  • cell density
  • cell infiltration
  • chronic pancreatitis
  • clinical article
  • clinical outcome
  • cohort analysis
  • colorimetry
  • controlled study
  • data analysis software
  • demography
  • differential diagnosis
  • female
  • flow cytometry
  • fluorescence imaging
  • gene expression
  • gene knockdown
  • glucose metabolism
  • human
  • human cell
  • in vivo study
  • intraductal papillary mucinous tumor
  • limit of quantitation
  • metabolic parameters
  • metabolome
  • mouse
  • neuroendocrine tumor
  • nonhuman
  • nuclear magnetic resonance spectroscopy
  • nuclear Overhauser effect
  • Panc02 cell line
  • pancreas adenocarcinoma
  • pancreas cancer
  • pancreas juice
  • pancreatectomy
  • papillary ampulla tumor
  • patient identification
  • peripheral blood mononuclear cell
  • prospective study
  • proton nuclear magnetic resonance
  • PT45 cell line
  • retrospective study
  • reverse transcription polymerase chain reaction
  • T lymphocyte
  • tumor associated leukocyte
  • upregulation

Fingerprint Dive into the research topics of 'Metabolome of pancreatic juice delineates distinct clinical profiles of pancreatic cancer and reveals a link between glucose metabolism and PD-1+Cells: Cancer Immunology Research'. Together they form a unique fingerprint.

Cite this